Kenya - English - Pharmacy and Poisons Board

m/s. stedman pharmaceuticals private limited c-4 sidco pharmaceutical complex alathur - dicyclomine hydrochloride and paracetamol tablets - tablet - each uncoated tablet contains: dicyclomine… - antispasmodics in combination with analgesics:

Kenya - English - Pharmacy and Poisons Board

m/s. hetero labs limited 7-2-a2, hetero corporate, industrial estates, - each film coated tablet contains 52.6 mg of… - film-coated tablet - each film coated tablet contains 52.6 mg of… - dolutegravir

Kenya - English - Pharmacy and Poisons Board

m/s. stedman pharmaceuticals private limited c-4 sidco pharmaceutical complex alathur - calcium magnesium zinc and colecalciferol tablets - tablet - each uncoated tablet contains: calcium citrate… - mineral supplements: calcium combinations with

Kenya - English - Pharmacy and Poisons Board

medley pharmaceuticals limited medley pharmaceuticals ltd. medley house d2 - domperidone tablets 10 mg - tablet - each uncoated tablet contains : domperidone 10 mg - propulsives

Namibia - English - Namibia Medicines Regulatory Council

sandoz s a (pty) ltd - each film coated tablet contains zolpidem tartarate 10,0mg - tablets - each film coated tablet contains zolpidem tartarate 10,0mg

Kenya - English - Pharmacy and Poisons Board

biopharmaltd 32547-00600 - alprazolam 0.5mg tablet - tablet - each tablet contains 0.5mg alprazolam - alprazolam

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - vigabatrin - granules for oral solution - 500 milligram(s) - fatty acid derivatives; vigabatrin

United States - English - NLM (National Library of Medicine)

dr. reddy’s laboratories inc., - vigabatrin (unii: gr120krt6k) (vigabatrin - unii:gr120krt6k) - vigabatrin for oral solution is indicated as adjunctive therapy for adults and pediatric patients 2 years of age and older with refractory complex partial seizures who have inadequately responded to several alternative treatments and for whom the potential benefits outweigh the risk of vision loss [see warnings and precautions ( 5.1 ) ]. vigabatrin for oral solution is not indicated as a first line agent for complex partial seizures. vigabatrin for oral solution is indicated as monotherapy for pediatric patients with infantile spasms 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss [see warnings and precautions ( 5.1 )]. none. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to aeds, including vigabatrin, during pregnancy. encourage women who are taking vigabatrin during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry. this can be done by calling the

United States - English - NLM (National Library of Medicine)

padagis us llc - vigabatrin (unii: gr120krt6k) (vigabatrin - unii:gr120krt6k) - vigabatrin for oral solution is indicated as adjunctive therapy for adults and pediatric patients 2 years of age and older with refractory complex partial seizures who have inadequately responded to several alternative treatments and for whom the potential benefits outweigh the risk of vision loss [see warnings and precautions (5.1)] . vigabatrin is not indicated as a first line agent for complex partial seizures. vigabatrin for oral solution is indicated as monotherapy for pediatric patients with infantile spasms 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss [see warnings and precautions (5.1)] . none. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to aeds, including vigabatrin, during pregnancy. encourage women who are taking vigabatrin during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry. this can be done by calling the toll-free number 1-888

United States - English - NLM (National Library of Medicine)

ascend laboratories, llc - vigabatrin (unii: gr120krt6k) (vigabatrin - unii:gr120krt6k) - vigabatrin for oral solution is indicated as adjunctive therapy for adults and pediatric patients 2 years of age and older with refractory complex partial seizures who have inadequately responded to several alternative treatments and for whom the potential benefits outweigh the risk of vision loss [see warnings and precautions (5.1)]. vigabatrin for oral solution is not indicated as a first line agent for complex partial seizures. vigabatrin for oral solution is indicated as monotherapy for pediatric patients with infantile spasms 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss [see warnings and precautions (5.1)]. none. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to aeds, including vigabatrin for oral solution, during pregnancy. encourage women who are taking vigabatrin for oral solution during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registr